Article Text

Download PDFPDF
Concurrent endocrine neoplasias in dogs and cats: a retrospective study (2004–2014)
  1. Laura Beatrice1,
  2. Felicitas Schär Boretti1,
  3. Nadja S Sieber-Ruckstuhl1,
  4. Claudia Mueller1,
  5. Claudia Kümmerle-Fraune1,
  6. Monika Hilbe2,
  7. Paula Grest2 and
  8. Claudia E Reusch1
  1. 1 Clinic for Small Animal Internal Medicine, Vetsuisse Faculty, University of Zurich, Zurich, Switzerland
  2. 2 Institute of Veterinary Pathology, Vetsuisse Faculty, University of zurich, Zurich, Switzerland
  1. E-mail for correspondence; creusch{at}


Multiple endocrine neoplasia (MEN) is a well-known syndrome in human medicine, whereas only a few cases of concurrent endocrine neoplasias have been reported in dogs and cats. The aim of this study was to evaluate the prevalence of concurrent endocrine neoplasias in dogs and cats at our clinic, identify possible breed and sex predispositions and investigate similarities with MEN syndromes in humans. Postmortem reports of 951 dogs and 1155 cats that died or were euthanased at the Clinic for Small Animal Internal Medicine, University of Zurich, between 2004 and 2014 were reviewed, and animals with at least two concurrent endocrine neoplasias and/or hyperplasias were included. Twenty dogs and 15 cats met the inclusion criteria. In dogs, the adrenal glands were most commonly affected. Multiple tumours affecting the adrenal glands and the association of these tumours with pituitary adenomas were the most common tumour combinations. Only one dog had a combination resembling human MEN type 1 syndrome (pituitary adenoma and insulinoma). In cats, the thyroid glands were most commonly affected and there were no similarities to human MEN syndromes. The prevalence of concurrent endocrine neoplasia was 2.1 per cent in dogs and 1.3 per cent in cats and MEN-like syndromes are very rare in these species.

  • adrenal gland
  • cats
  • dogs
  • endocrinology
  • neoplasia
  • tumours
View Full Text

Statistics from


  • Competing interests None declared.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.